Northern Trust’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $143K | Sell |
123,444
-338,859
| -73% | -$393K | ﹤0.01% | 4029 |
|
|
2025
Q1 | $735K | Sell |
462,303
-22,435
| -5% | -$35.7K | ﹤0.01% | 3409 |
|
|
2024
Q4 | $1.47M | Buy |
484,738
+10,513
| +2% | +$31.9K | ﹤0.01% | 3185 |
|
|
2024
Q3 | $1.75M | Sell |
474,225
-21,041
| -4% | -$77.4K | ﹤0.01% | 3084 |
|
|
2024
Q2 | $2.03M | Sell |
495,266
-28,436
| -5% | -$116K | ﹤0.01% | 2889 |
|
|
2024
Q1 | $8.25M | Sell |
523,702
-6,301
| -1% | -$99.3K | ﹤0.01% | 2168 |
|
|
2023
Q4 | $8.03M | Sell |
530,003
-10,719
| -2% | -$162K | ﹤0.01% | 2212 |
|
|
2023
Q3 | $10.8M | Buy |
540,722
+61,919
| +13% | +$1.24M | ﹤0.01% | 1946 |
|
|
2023
Q2 | $13.5M | Buy |
478,803
+51,932
| +12% | +$1.47M | ﹤0.01% | 1855 |
|
|
2023
Q1 | $7.34M | Buy |
426,871
+6,827
| +2% | +$117K | ﹤0.01% | 2224 |
|
|
2022
Q4 | $8.46M | Buy |
420,044
+3,002
| +0.7% | +$60.5K | ﹤0.01% | 2124 |
|
|
2022
Q3 | $9.03M | Buy |
417,042
+43,142
| +12% | +$934K | ﹤0.01% | 2048 |
|
|
2022
Q2 | $10.5M | Buy |
373,900
+34,669
| +10% | +$974K | ﹤0.01% | 1990 |
|
|
2022
Q1 | $15.7M | Sell |
339,231
-10,534
| -3% | -$486K | ﹤0.01% | 1849 |
|
|
2021
Q4 | $29.4M | Buy |
349,765
+1,433
| +0.4% | +$120K | ﹤0.01% | 1504 |
|
|
2021
Q3 | $23.2M | Buy |
348,332
+41,002
| +13% | +$2.73M | ﹤0.01% | 1688 |
|
|
2021
Q2 | $16.4M | Buy |
307,330
+24,007
| +8% | +$1.28M | ﹤0.01% | 2031 |
|
|
2021
Q1 | $12.3M | Buy |
283,323
+881
| +0.3% | +$38.2K | ﹤0.01% | 2162 |
|
|
2020
Q4 | $14.7M | Buy |
282,442
+138,550
| +96% | +$7.2M | ﹤0.01% | 2015 |
|
|
2020
Q3 | $4.7M | Buy |
143,892
+11,356
| +9% | +$371K | ﹤0.01% | 2569 |
|
|
2020
Q2 | $6.36M | Buy |
+132,536
| New | +$6.36M | ﹤0.01% | 2368 |
|